Amir Dan Rubin
Chief Executive Officer @ Amazon One Medical
San Francisco Bay Area, United States
Amir Dan Rubin is a Series B investor at Amazon One Medical in San Francisco Bay Area focused on Health Care and Medical. Amir Dan Rubin is the Chief Executive Officer at One Medical. Amir is focused on delivering better health through outstanding, coordinated clinical care; innovative digital technology; and the highest levels of service, access, and engagement. Previously, as EVP and divisional CEO of UnitedHealth Group’s Optum division, he oversaw a number ofbusiness lines focused on helping to make the health system work better for everyone. Prior to Optum, Amir was president and CEO of Stanford Health Care where he helped raise patient experience and quality scores to the highest levels in the nation, grow a regional network of care settings, and advance digital health and corporate partnerships in the heart of Silicon Valley. Amir also previously served as COO for the UCLA Health System, and has been awarded the EY Entrepreneur of the Year Award in Northern California in recognition of his role in innovation and industry transformation. He holds MBA and MHSA degrees from the University of Michigan.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Amir Dan Rubin invests in
Stages Amir Dan Rubin invests in
Countries Amir Dan Rubin invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 5 (50%)
- Medical 3 (30%)
- Artificial Intelligence 3 (30%)
- B2B 1 (10%)
- SaaS 1 (10%)
Stage
- Series B 4 (40%)
- Series A 3 (30%)
- Seed 1 (10%)
- Funding Round 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
A modern prescription network | $16M / Series A / Apr 30, 2026 | |
|
|
Qualified Health is a reliable partner for safely utilizing generative AI in medicine. Qualified Health's infrastructure solution offers safeguards for ongoing algorithm performance monitoring, active AI governance, and developing agents tailored to the healthcare industry. Qualified Health are revolutionizing healthcare in America with tophealth system partners. | $125M / Series B / Mar 25, 2026 | |
|
|
Zarminali Health transforms pediatric care by building multispecialty pediatric group that provides modern, seamlessly coordinated care. | $110M / Series A / Jan 21, 2026 | |
|
|
Amae Health provides outpatient care that integrates psychiatric treatment, primary care, therapy, and peer support for adults living with severe mental illness. The company delivers personalized treatment plans through multidisciplinary teams comprising psychiatrists, therapists, primary care physicians, health coaches, dietitians, and peermentors. Its services cover conditions such as schizophrenia, bipolar disorder, refractory depression, trauma, and co-occurring substance-use disorders, and it emphasizes long-term engagement and whole-person wellness. Amae Health also collaborates with academic medical centers to develop clinician training programs and to use data-driven insights to refine care pathways. | $25M / Series B / Nov 06, 2025 | |
|
|
Hyro creates plug-and-play conversational AI assistants by seamlessly ingesting data on digital channels to allow users to interact with information via voice or chat simply and intuitively, allowing for increased engagement and conversions. Unlike existing solutions, Hyro provides organisations with frictionless deployment and maintenanceprocesses by automatically building a knowledge graph out of their existing content without any integration, playbooks, or training data. | $45M / Oct 21, 2025 | |
|
|
Qualified Health is a reliable partner for safely utilizing generative AI in medicine. Qualified Health's infrastructure solution offers safeguards for ongoing algorithm performance monitoring, active AI governance, and developing agents tailored to the healthcare industry. Qualified Health are revolutionizing healthcare in America with tophealth system partners. | $30M / Seed / Jan 08, 2025 | |
|
|
Hyro creates plug-and-play conversational AI assistants by seamlessly ingesting data on digital channels to allow users to interact with information via voice or chat simply and intuitively, allowing for increased engagement and conversions. Unlike existing solutions, Hyro provides organisations with frictionless deployment and maintenanceprocesses by automatically building a knowledge graph out of their existing content without any integration, playbooks, or training data. | $15M / Series B / Dec 10, 2024 | |
|
|
Amae Health provides outpatient care that integrates psychiatric treatment, primary care, therapy, and peer support for adults living with severe mental illness. The company delivers personalized treatment plans through multidisciplinary teams comprising psychiatrists, therapists, primary care physicians, health coaches, dietitians, and peermentors. Its services cover conditions such as schizophrenia, bipolar disorder, refractory depression, trauma, and co-occurring substance-use disorders, and it emphasizes long-term engagement and whole-person wellness. Amae Health also collaborates with academic medical centers to develop clinician training programs and to use data-driven insights to refine care pathways. | $15M / Series A / Apr 25, 2024 | |
|
|
Ezra has created a new way to screen for cancer using full-body MRI technology assisted by Artificial Intelligence. The company's first AI, developed to assist radiologists when interpreting MRI images of the prostate, is an FDA-cleared software as a medical device. | $21M / Series B / Feb 07, 2024 | |
|
|
Ezra has created a new way to screen for cancer using full-body MRI technology assisted by Artificial Intelligence. The company's first AI, developed to assist radiologists when interpreting MRI images of the prostate, is an FDA-cleared software as a medical device. | $21M / Series B / Feb 07, 2024 |
Co-Investors
About Amazon One Medical
Amazon One Medical is a members-only technology platform offering an array of concierge medical services. The integration of these elements allows a seamless experience that not only saves the patients time and money but also leads to better health outcomes and happier lives. The company attracts the highest caliber team of healthcare providers,allowing them to practice medicine the way it should be. It makes access to care frictionless with face-to-face virtual video visits available anytime. It allows practicing medicine the way it should be practiced, focusing on improving the patient experience and challenging the healthcare status quo.
Amazon One Medical Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Amir Dan Rubin
Chief Executive Officer
|
|||
|
Bethany Andres-Beck
Staff Software Engineer
|
|||
|
Bjorn Thaler
Chief Financial Officer
|
|||
|
Christine Morehead
Chief People Officer
|
|||
|
Doug Sweeny
Chief Marketing Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Amir Dan Rubin invest in?
Amir Dan Rubin invests primarily in Health Care, Medical and Artificial Intelligence startups, most often at Series B and Series A stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Amir Dan Rubin?
Public channels for Amir Dan Rubin include LinkedIn and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Amir Dan Rubin last invest?
The most recent investment recorded for Amir Dan Rubin closed in Apr 2026. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!